Nutex Health Announces Q2 2025 Financial Results Release and Conference Call
PorAinvest
sábado, 9 de agosto de 2025, 4:38 pm ET1 min de lectura
NUTX--
Investors and financial professionals can access the conference call via phone at 1-877-407-9208 or 1-201-493-6784, or through the designated participant link [2]. For those unable to attend the live call, a recording will be available on the company’s website.
Nutex Health operates 24 micro hospitals across 11 states, with a market capitalization of $506.35 million as of July 2, 2025. The company's significant insider ownership stands at 35.81% [1].
Analysts expect Nutex Health to report a 145.4% increase in revenue to $186.686 million for the quarter ending June 30, 2025, compared to $76.08 million a year ago. The mean estimate for earnings per share (EPS) is a loss of $1.58, with a "buy" rating from analysts [4].
The upcoming financial results will provide insights into Nutex Health's performance during the second quarter of 2025, following the strong growth reported in the first quarter of the year. The company's ability to execute its growth strategy and navigate regulatory changes will be key factors to watch [1].
References:
[1] https://www.nutexhealth.com/nutex-health-schedules-2025-second-quarter-financial-results-release-and-conference-call/
[2] https://www.stocktitan.net/news/NUTX/nutex-health-schedules-2025-second-quarter-financial-results-release-gtqrwjpqugi6.html
[4] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TW0N6:0-nutex-health-inc-expected-to-post-a-loss-of-1-58-a-share-earnings-preview/
Nutex Health will release Q2 2025 financial results on August 14, 2025, after market close, and hold a conference call on August 15, 2025, at 10:30 a.m. ET. Interested parties can dial in or access the call via a designated link. The company operates 24 micro hospitals across 11 states and has a market cap of $506.35 million, with significant insider ownership at 35.81%.
Nutex Health Inc. (NASDAQ: NUTX), a physician-led healthcare delivery system, has scheduled the release of its second quarter 2025 financial results for August 14, 2025, after the close of the market. The company will discuss these results during a conference call on August 15, 2025, at 10:30 a.m. ET [1].Investors and financial professionals can access the conference call via phone at 1-877-407-9208 or 1-201-493-6784, or through the designated participant link [2]. For those unable to attend the live call, a recording will be available on the company’s website.
Nutex Health operates 24 micro hospitals across 11 states, with a market capitalization of $506.35 million as of July 2, 2025. The company's significant insider ownership stands at 35.81% [1].
Analysts expect Nutex Health to report a 145.4% increase in revenue to $186.686 million for the quarter ending June 30, 2025, compared to $76.08 million a year ago. The mean estimate for earnings per share (EPS) is a loss of $1.58, with a "buy" rating from analysts [4].
The upcoming financial results will provide insights into Nutex Health's performance during the second quarter of 2025, following the strong growth reported in the first quarter of the year. The company's ability to execute its growth strategy and navigate regulatory changes will be key factors to watch [1].
References:
[1] https://www.nutexhealth.com/nutex-health-schedules-2025-second-quarter-financial-results-release-and-conference-call/
[2] https://www.stocktitan.net/news/NUTX/nutex-health-schedules-2025-second-quarter-financial-results-release-gtqrwjpqugi6.html
[4] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TW0N6:0-nutex-health-inc-expected-to-post-a-loss-of-1-58-a-share-earnings-preview/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios